Losartan Potassium Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 25 mg, 50 mg, 100 mg
Reference Brands: Cozaar(US & EU)
Category:
Heart Disorder
Losartan is an angiotensin receptor blocker (ARB) that prevents angiotensin II from binding to its receptors, causing vasodilation. It lowers blood pressure, reduces the risk of stroke, and protects kidney function in diabetics. Benefits include effective hypertension control, improved cardiovascular health, and decreased heart failure progression.
Losartan Potassium tablet is available in Tablet
and strengths such as 25 mg, 50 mg, 100 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Losartan Potassium tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Losartan Potassium tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Losartan tablets, marketed as Cozaar, are approved in the US by the FDA and in the EU via EMA for treating hypertension, protecting kidney function, and reducing cardiovascular events. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews detailed clinical trial data and manufacturing processes, while the EMA ensures compliance with regional safety and quality regulations. For guidance on dossier preparation, regulatory pathways, and market strategies, visit PharmaTradz. Ensuring regulatory adherence supports timely approval, safe use, and global availability of losartan tablets, helping improve cardiovascular health outcomes worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing